Matinas Biopharma Holdings Inc

ASE:MTNB   4:00:00 PM EDT
+0.01 (+1.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)87.88M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.3 Million
Adjusted EPS-$0.03
See more estimates
10-Day MA$0.41
50-Day MA$0.50
200-Day MA$0.59
See more pivots

Matinas Biopharma Holdings Inc Stock, ASE:MTNB

1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921-9999
United States of America
Phone: +1.908.484.8805
Number of Employees: 34


Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.